DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/k2qh2c/global_migraine) has announced the addition of the "Global Migraine Epidemiology and Patient Flow Analysis - 2012" report to their offering.
Fore Pharma announced the results of its Migraine patient population study in a new report Global Migraine Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Migraine epidemiology, Migraine diagnosed patients, and Migraine treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Migraine derived from epidemiological analysis, percentage of patients diagnosed with Migraine, and percentage of patients treated with Migraine therapy.
The study helps executives estimate Migraine market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Migraine prevalence, Migraine diagnosis rate, and Migraine treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Migraine: Disease Definition
- Migraine Patient Flow
- Migraine Prevalence
- Migraine Diagnosed Patients
- Migraine Treated Patients
Key Topics Covered:
1. Migraine: Disease Definition
2. Global Migraine Patient Flow
3. Migraine Patient Flow in the US
4. Migraine Patient Flow in Europe
5. Migraine Patient Flow in Germany
6. Migraine Patient Flow in France
7. Migraine Patient Flow in Spain
8. Migraine Patient Flow in Italy
9. Migraine Patient Flow in UK
10. Migraine Patient Flow in Japan
11. Appendix
12. Research Methodology
For more information visit http://www.researchandmarkets.com/research/k2qh2c/global_migraine